Moon BJ et al. |
Effect of chronic rhinosinusitis on liver transplant patients. |
2009 Sep-Oct |
Am J Rhinol Allergy |
pmid:19807981
|
Reams BD and Palmer SM |
Sublingual tacrolimus for immunosuppression in lung transplantation: a potentially important therapeutic option in cystic fibrosis. |
2002 |
Am J Respir Med |
pmid:14720063
|
Lee J et al. |
Inpatient rehabilitation challenges in a quadrimembral amputee after bilateral hand transplantation. |
2011 |
Am J Phys Med Rehabil |
pmid:21765280
|
Laifer SA et al. |
Pregnancy after cardiac transplantation. |
1994 |
Am J Perinatol |
pmid:7519426
|
Tulaci KG et al. |
The effect of tacrolimus on facial nerve injury: Histopathological findings in a rabbit model. |
|
Am J Otolaryngol |
pmid:27465503
|
Knott PD et al. |
Induction with T-cell receptor antibody leads to long-term laryngeal allograft function. |
2008 Nov-Dec |
Am J Otolaryngol |
pmid:19144301
|
Yang GS et al. |
Intratympanic immunosuppressives for prevention of immune-mediated sensorineural hearing loss. |
2000 |
Am J Otol |
pmid:10912694
|
Pezze JL and Whiteman K |
Transplantation's newest weapon FK 506. |
1991 |
Am J Nurs |
pmid:1716857
|
Taormina D et al. |
Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers. |
1992 |
Am J Hosp Pharm |
pmid:1373936
|
Min DI et al. |
Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection. |
1992 |
Am J Hosp Pharm |
pmid:1282779
|
|
Tacrolimus introduced for use in liver transplantation. |
1994 |
Am J Hosp Pharm |
pmid:7524317
|
Przepiorka D et al. |
Blood tacrolimus concentration unchanged by plasmapheresis. |
1994 |
Am J Hosp Pharm |
pmid:7524318
|
Matsunami H et al. |
New technique for measuring tacrolimus concentrations in blood. |
1994 |
Am J Hosp Pharm |
pmid:7510929
|
|
Roche, FDA announce new drug-interaction warnings for mibefradil. |
1998 |
Am J Health Syst Pharm |
pmid:9492249
|
Ku YM et al. |
Compatibility of tacrolimus injection with cimetidine hydrochloride injection in 0.9% sodium chloride injection. |
1995 |
Am J Health Syst Pharm |
pmid:8528874
|
Greanya ED et al. |
Pharmacokinetics of tacrolimus and mycophenolate mofetil in renal transplant recipients on a corticosteroid-free regimen. |
2012 |
Am J Health Syst Pharm |
pmid:22215359
|
Heavner MS et al. |
Clinical outcomes associated with conversion from brand-name to generic tacrolimus in hospitalized kidney transplant recipients. |
2013 |
Am J Health Syst Pharm |
pmid:23943182
|
Curtin BF et al. |
Unusually late-onset mycophenolate mofetil-related colitis. |
2014 |
Am J Health Syst Pharm |
pmid:25320135
|
Bonhomme-Faivre L et al. |
Effect of the ABCB1 3435C>T polymorphism on tacrolimus concentrations and dosage requirements in liver transplant recipients. |
2009 |
Am J Health Syst Pharm |
pmid:19729569
|
Lee JH et al. |
Stability of tacrolimus solutions in polyolefin containers. |
2016 |
Am J Health Syst Pharm |
pmid:26796907
|
|
Tacrolimus. |
2001 |
Am J Health Syst Pharm |
pmid:11794952
|
Lee B et al. |
Appropriate timing of tacrolimus concentration measurements in the emergency department. |
2016 |
Am J Health Syst Pharm |
pmid:27543574
|
Jacobson PA et al. |
Stability of tacrolimus in an extemporaneously compounded oral liquid. |
1997 |
Am J Health Syst Pharm |
pmid:9117806
|
Utecht KN et al. |
Effects of genetic polymorphisms on the pharmacokinetics of calcineurin inhibitors. |
2006 |
Am J Health Syst Pharm |
pmid:17106006
|
Kelly PA et al. |
Tacrolimus: a new immunosuppressive agent. |
1995 |
Am J Health Syst Pharm |
pmid:7552894
|
MacDonald AS and Sketris IS |
Tacrolimus in transplantation. |
1995 |
Am J Health Syst Pharm |
pmid:7552906
|
Johnson CE et al. |
Stability of tacrolimus with morphine sulfate, hydromorphone hydrochloride, and ceftazidime during simulated intravenous coadministration. |
1999 |
Am J Health Syst Pharm |
pmid:10030533
|
Pennington CA and Park JM |
Sublingual tacrolimus as an alternative to oral administration for solid organ transplant recipients. |
2015 |
Am J Health Syst Pharm |
pmid:25631834
|
Tsapepas DS et al. |
Managing the atazanavir-tacrolimus drug interaction in a renal transplant recipient. |
2011 |
Am J Health Syst Pharm |
pmid:21200061
|
Myers AL et al. |
Stability of tacrolimus injection diluted in 0.9% sodium chloride injection and stored in Excel bags. |
2016 |
Am J Health Syst Pharm |
pmid:27919876
|
Grouzmann E et al. |
Misleading tacrolimus concentration value in blood taken from a catheter used for tacrolimus administration. |
2008 |
Am J Health Syst Pharm |
pmid:18216007
|
Kasper RC et al. |
Anetoderma arising in cutaneous B-cell lymphoproliferative disease. |
2001 |
Am J Dermatopathol |
pmid:11285407
|
Gupta AK and Versteeg SG |
Topical Treatment of Facial Seborrheic Dermatitis: A Systematic Review. |
2017 |
Am J Clin Dermatol |
pmid:27804089
|
Yang LP and Curran MP |
Spotlight on topical pimecrolimus in pediatric atopic dermatitis. |
2010 |
Am J Clin Dermatol |
pmid:20509720
|
Cheer SM and Plosker GL |
Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis. |
2001 |
Am J Clin Dermatol |
pmid:11770393
|
Ozden MG et al. |
Topical pimecrolimus 1% cream for resistant seborrheic dermatitis of the face: an open-label study. |
2010 |
Am J Clin Dermatol |
pmid:20000875
|
Mertens JS et al. |
Morphea and Eosinophilic Fasciitis: An Update. |
2017 |
Am J Clin Dermatol |
pmid:28303481
|
Frankel HC and Qureshi AA |
Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis. |
2012 |
Am J Clin Dermatol |
pmid:22263704
|
Iskedjian M et al. |
Topical calcineurin inhibitors in the treatment of atopic dermatitis: a meta-analysis of current evidence. |
2004 |
Am J Clin Dermatol |
pmid:15301573
|
Kroft EB et al. |
Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study. |
2009 |
Am J Clin Dermatol |
pmid:19354332
|
Siegfried EC et al. |
Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice. |
2013 |
Am J Clin Dermatol |
pmid:23703374
|
Tjioe M et al. |
Topical macrolide immunomodulators: a role in the treatment of vitiligo? |
2006 |
Am J Clin Dermatol |
pmid:16489839
|
Valdivielso-Ramos M et al. |
Significant improvement in extensive lichen sclerosus with tacrolimus ointment and PUVA. |
2008 |
Am J Clin Dermatol |
pmid:18429647
|
Wellington K and Noble S |
Pimecrolimus: a review of its use in atopic dermatitis. |
2004 |
Am J Clin Dermatol |
pmid:15663345
|
Cook BA and Warshaw EM |
Role of topical calcineurin inhibitors in the treatment of seborrheic dermatitis: a review of pathophysiology, safety, and efficacy. |
2009 |
Am J Clin Dermatol |
pmid:19222250
|
Ingram JR et al. |
Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis. |
2009 |
Am J Clin Dermatol |
pmid:19489656
|
Reitamo S et al. |
Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitis. |
2002 |
Am J Clin Dermatol |
pmid:12113647
|
Lübbe J et al. |
Safety, efficacy, and dosage of 1% pimecrolimus cream for the treatment of atopic dermatitis in daily practice. |
2006 |
Am J Clin Dermatol |
pmid:16605292
|
Ellis CN et al. |
Cost effectiveness of management of mild-to-moderate atopic dermatitis with 1% pimecrolimus cream in children and adolescents 2-17 years of age. |
2006 |
Am J Clin Dermatol |
pmid:16605293
|
Wollina U |
The role of topical calcineurin inhibitors for skin diseases other than atopic dermatitis. |
2007 |
Am J Clin Dermatol |
pmid:17492844
|